DEA Hears Cannabis Withdrawal Is a 'Dying Ember' While States Bet the Opposite Way

On June 29, 2026, in a hearing room in Arlington, Virginia, a government-picked witness told a DEA administrative law judge that opioid withdrawal is “a dumpster fire” and marijuana withdrawal is “more like a dying glowing ember” — a line meant to settle, in one image, whether cannabis deserves to stay in the same legal category as heroin. It’s the opening day of the DEA’s rescheduling hearing, the actual evidentiary phase of a Schedule I to Schedule III review that’s dragged for years, running through July 15. DEA selected seven participants to testify. All seven oppose rescheduling. Advocacy groups that applied to testify were rejected for not being “adversely affected” by the current law — as if the people who’ve spent years living inside Schedule I don’t count as affected parties.

That’s not a hearing. That’s a verdict wearing courtroom furniture.

Meanwhile the ground is moving the other direction, fast. On July 1, Georgia’s “Putting Georgia’s Patients First Act” took effect, and it doesn’t nibble at the margins — it kills the state’s 5% THC potency cap outright, triples possession limits to 12,000mg, and legalizes gummies, edibles, and vaporized flower at dispensaries for the first time, while adding Stage III HIV, lupus, autism, and severe Alzheimer’s as qualifying conditions (CBS News Atlanta). Same day, every Pennsylvania Democratic state senator signed a discharge resolution to force a stalled adult-use legalization bill out of the GOP-chaired committee sitting on it (Marijuana Moment).

Wall Street isn’t waiting for the DEA’s paperwork either. Glass House Brands started trading on the NYSE under ticker GLAS on June 30, one day into the hearing, following Trulieve’s debut earlier in June — CEO Kyle Kazan said the listing was a direct bet on Schedule III opening up institutional capital cannabis has never had (Business of Cannabis).

Picture the split screen: a federal judge is hearing sworn testimony that cannabis withdrawal barely counts as withdrawal, while Georgia patients walk into dispensaries for products that were illegal there two days earlier, and a cannabis company rings the opening bell betting the federal government eventually catches up to what states already decided. For people actually withdrawing from cannabis — and it is real, whatever one hand-picked witness wants to call it — the message coming out of Arlington is that your experience doesn’t merit a seat at the table unless you showed up to argue against your own case. The rest of the country stopped waiting for that permission a while ago.